Besifovir therapy improves hepatic histology and reduces covalently closed circular DNA in chronic hepatitis B patients.
Hyung Joon YimWon KimSang Hoon AhnYoung-Kul JungSoon Ho UmJoo Hyun SohnJae Young JangDong Joon KimEun-Sook ParkSo-Young JinKyun-Hwan KimPublished in: Journal of gastroenterology and hepatology (2021)
The BSV therapy improves hepatic histology and decreases intrahepatic cccDNA in CHB patients.